Cargando…
EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
Autores principales: | Schotten, Nienke, Laarakkers, Coby M. M., Roelofs, Rian W., Origa, Raffaella, van Kraaij, Marian G. J., Swinkels, Dorine W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324624/ https://www.ncbi.nlm.nih.gov/pubmed/28033686 http://dx.doi.org/10.1002/ajh.24636 |
Ejemplares similares
-
Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform
por: Laarakkers, Coby M. M., et al.
Publicado: (2013) -
Iron Supplementation in Suckling Piglets: How to Correct Iron Deficiency Anemia without Affecting Plasma Hepcidin Levels
por: Starzyński, Rafał R., et al.
Publicado: (2013) -
Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing
por: Diepeveen, Laura E., et al.
Publicado: (2019) -
Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry
por: Swinkels, Dorine W., et al.
Publicado: (2008) -
PB2544: GAUCHER-LIKE CELLS IN THALASSEMIA INTERMEDIA: IS IT A CHALLENGE?
por: Komninaka, Veroniki, et al.
Publicado: (2023)